New vaccine aims to protect older adults from severe flu complications
Sanofi has announced the launch of its high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK. This vaccine is designed for people aged 65 and older, as well as clinically at-risk individuals aged 60 to 64.
Sanofi launches high-dose flu vaccine in the UK – PharmaTimes